Yep, YP plant is a foregone conclusion. Only potential risk at this stage is regulatoey approval (Hebang increasing stake in AEV).
Ann: Strategic Investment from Sichuan Hebang Biotechnology, page-79
-
- There are more pages in this discussion • 194 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AEV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.9¢ |
Change
-0.001(5.26%) |
Mkt cap ! $24.33M | |||
| Open | High | Low | Value | Volume |
| 0.9¢ | 0.9¢ | 0.9¢ | $3.752K | 416.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 2796798 | 0.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.0¢ | 300000 | 1 |
View Market Depth
| Last trade - 13.54pm 12/11/2024 (20 minute delay) ? |
| AEV (ASX) Chart |